Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
GI Dynamics plans to hold a special shareholders meeting to vote on a proposed 1-for-10 reverse stock split in an effort to raise the company’s lagging share price.
The meeting is slated to be held Nov. 10 in Boston. Voting will be restricted to shareholders of record as of the close of business Oct. 4. Read more
Boston Scientific said it won FDA and CE Mark approval in Europe for its CoverEdge 32 and CoverEdge X 32 surgical leads, touting them as the world’s 1st 32-contact leads for treating chronic pain.
The CoverEdge leads are designed to be used with Boston Scientific’s Precision Spectra spinal cord stimulator, according to a press release. Read more
Shares of Medtronic and Covidien both closed up after Medtronic affirmed its intention to consummate a $43 billion union with Covidien.
In a regulatory filing, Medtronic said it now expects the deal to close late in the 4th quarter or early in 2015. Investors reacted by sending COV shares up 4.5% to an $89.25 close yesterday; MDT shares closed up 1.8% at $64.98 each. Read more